IFT122 and systemic lupus erythematosus: Thus, the identification of TRIM-21 as a negative regulator of CED-1 will have important implications for understanding its role in the pathogenesis of human autoimmune diseases, such as SLE, and neurodegenerative diseases, such as Alzheimer’s disease, in addition to the mechanistic insights into its role in AC clearance.